Treatment of Hematologic Neoplasms with New Immunomodulatory Drugs (IMiDs)
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Oncology
Link
http://link.springer.com/content/pdf/10.1007/s11864-008-0077-x.pdf
Reference102 articles.
1. Vallet S, Palumbo A, Raje N, Boccadoro M, Anderson KC: Thalidomide and lenalidomide: mechanism-based potential drug combinations. Leuk Lymphoma 49:1238–1245, 2008. doi: 10.1080/10428190802005191
2. Aragon-Ching JB, Li H, Gardner ER, Figg WD: Thalidomide analogues as anticancer drugs. Recent Patents Anticancer Discov 2:167–174, 2007.
3. Paravar T, Lee DJ: Thalidomide: mechanisms of action. Int Rev Immunol 27:111–135, 2008. doi: 10.1080/08830180801911339
4. Singhal S, Mehta J, Desikan R, Ayers D, Roberson P, Eddlemon P, Munshi N, Anaissie E, Wilson C, Dhodapkar M, Zeldis J, Barlogie B: Antitumor activity of thalidomide in refractory multiple myeloma. N Engl J Med 341:1565–1571, 1999. doi: 10.1056/NEJM199911183412102
5. Zhu D, Corral LG, Fleming YW, et al.: Immunomodulatory drugs Revlamid® (lenalidomide) and CC-4047 induce apoptosis of both hematological and solid tumor cells through NK cell activation.␣Cancer Immunol Immunother, 2008, 57:1849–1851
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. What Is Different in Acute Hematologic Malignancy-Associated ARDS? An Overview of the Literature;Medicina;2022-09-03
2. Thalidomidkezelés relabált, diffúz nagy B-sejtes lymphomában idős betegekben. Három eset bemutatása;Orvosi Hetilap;2017-10
3. Anti-tumor activity and relative mechanism of ethanolic extract of Marsdenia tenacissima (Asclepiadaceae) against human hematologic neoplasm in vitro and in vivo;Journal of Ethnopharmacology;2014-04
4. Chronic lymphocytic leukaemia - the role of the microenvironment pathogenesis and therapy;British Journal of Haematology;2013-04-25
5. Cap-Dependent Protein Translation Initiation in Multiple Myeloma: An Attractive Target for Therapy;Genetic and Molecular Epidemiology of Multiple Myeloma;2012-11-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3